Prophylaxis Of Acute Rejection In Allogeneic Renal Transplantation Used In Combination With Ciclosporin And Corticosteroid-containing Immunosuppression Regimens:
By IV Inj Or By IV Infusion:
Adult: Initially 20 Mg, Administered Within 2 Hours Before Transplant Surgery, Followed By 20 Mg After4 Days After Surgery, Withhold Second Dose If Severe Hypersensitivity Or Graft Loss Occurs
Children Above 2 Yrs Weighing Less Than 40 Kg: 10 Mg Per Dose; Weighing 40 Kg Or More, Same As Adult Dose
Content
Inj: Basiliximab 20mg; Powder In Vial Plus Diluent
Pregnancy
Consult with Doctor Or Caution Advised
Stability
Immunosuppressant
Anti-lymphocyte
Interleukin-2 Receptor Antagonist
Contra Indications
Pregnancy, Lactation For At Least 8 Weeks After The Second Dose.
Precautions
Pregnancy, Lactation For At Least 8 Weeks After The Second Dose.
Lactation
Consult with Doctor Or Caution Advised
Side Effects
Atrial Flutter
Cardiac Arrest
Cytokine Release Syndrome
Palpitations
Severe Hypersensitivity Reactions
Anaphylactoid Type Reaction Such As Rash
Urticaria
Sneezing
Wheezing
Bronchospasm
Pulmonary Oedema
Cardiac Failure
Respiratory Failure And Capillary Leak Syndrome Have Been Reported.